Preoperative and Postoperative Spirometry in Patients Undergoing Lobectomy for Sequelae of Pulmonary Tuberculosis

Abstract

Objective: To assess preoperative and postoperative spirometry values in patients undergoing lobectomy for sequelae of pulmonary tuberculosis. Method: A total of 20 patients (10 males) with history of treatment for tuberculosis and presenting with symptomatic sequelae (repeat infection or hemoptysis) who sought assistance at the chest surgery outpatient clinic between 11.09.07 and 04.02.10, were selected for the study. Only patients that met theeligibility criteria (symptomatic, submitted to tuberculosis treatment) were included in the study. The age of patients ranged from 15 to 56 years (mean: 35.75 years). The average treatment time for tuberculosis was 6 months and onset of symptoms occurred between 01 and 32 years after treatment. To assess the impact of surgery on the variables VC, FVC, FEV1, FEV1/FVC, FEF and PEF preoperative values were compared with postoperative values at 1st, 3rd, 6th and 12th month using the paired t test. The level of significance (α) applied for all tests was 5% where a value of p < 0.05 was considered significant. Results: 11 patients were treated because of recurrent infections and 9 because of haemoptysis. The most common lobectomy was right upper lobectomy (7 patients), followed by left upper lobectomy (6 patients), left lower lobectomy (6 patients), and right middle lobectomy (1 patient). There were no postoperative complications. There was no postoperative mortality. Conclusion: Based on the results of the present study, it can be concluded that, at the 12th postoperative month, spirometric parameters of patients with tuberculosis sequelae submitted to lobectomy had returned to preoperative levels.

Share and Cite:

E. Amorim, R. Saad and A. Filho, "Preoperative and Postoperative Spirometry in Patients Undergoing Lobectomy for Sequelae of Pulmonary Tuberculosis," Open Journal of Thoracic Surgery, Vol. 3 No. 2, 2013, pp. 37-41. doi: 10.4236/ojts.2013.32008.

1. Introduction

Tuberculosis (TB) remains common in some countries including Brazil [1]. TB continues into the 21st century as an unresolved public health problem representing an important cause of morbi-mortality [2]. It is the most common infectious disease in humans [3] and the cause of death in around 3 million people worldwide annually, being the third most prevalent infectious disease but having the highest death rate [4]. TB is perhaps the oldest disease known to man, with records of lesions found in the vertebrae of Egyptian mummies dating back almost four thousand years [5-8].

Currently, TB is placed in a unique epidemiological and socioeconomic context characterized by a global demographic transition which has led to a marked aging of the population [1,9].

Diagnosis of disease activity in patients with pulmonary tuberculosis (PTB) is based on multiple factors such as clinical status, physical exam, tuberculin test and mainly on the detection of the bacillus in sputum, bronchialveolar lavage, transtracheal aspirate or lung tissue biopsy samples. These factors are supported by others such as sequential changes on chest radiographs and previous history of anti-tuberculosis therapy [1,10].

With the advent of modern chemotherapy, a dramatic reduction in tuberculosis ensued, commencing with the discovery of streptomycin in 1944 and the anti-tuberculosis activity of isoniazid in 1952 [11,12].

The most frequent sequelae of tuberculosis are lung damage, bronchiectasis, fungal ball, tracheal stenosis in addition to other less common sequelae [13].

The pulmonary function test, ventilatory test or spirometry, is extremely important for indications of surgical treatment because it is used to assess whether the patient can tolerate anesthesia and if morbimortality is increased. [14]

Specifically for tuberculosis, a frequently occurring disease in Brazil, particularly in Maranhão state, few references are available in the literature of studies investigating alterations in lung function after resection of the parenchyma [15].

The School of Medical Sciences of the Santa Casa de São Paulo Hospital (FCMSCSP), among their research lines, is currently conducting studies involving the assessment of preoperative and postoperative pulmonary function tests. Many of these studies have been concluded [16-19].

Against this background, and providing continuity to the line of research pursued by the institution, we sought to assess preoperative and postoperative spirometry values in patients undergoing lobectomy for sequelae of previously treated pulmonary tuberculosis. This is the first study of this nature ever undertaken in our medical setting.

2. Method

The study was approved by the Research Ethics Committee of the Hospital Universitário Unidade Presidente Dutra—HUUFMA.

A total of 20 patients (10 males) with history of treatment for tuberculosis and presenting with symptomatic sequelae i.e. repeat infection or hemoptysis, who sought the chest surgery outpatient clinic of the Hospital Universitário Presidente Dutra of the Federal University of Maranhão between 11.09.07 and 04.02.10, were selected for the study.

In the sample studied, patient age ranged from 15 to 56 years (mean = 3575 years), the treatment time for tuberculosis was 06 months and onset of symptoms occurred between 01 and 32 (mean = 7.8 years) years after treatment.

After clinical interview with reporting of recurrent hemoptysis and previous history of treated tuberculosis, chest radiograph and CT exams were ordered.

With radiologically-confirmed diagnosis of sequelae, pre-operative exams were requested: perfusion scintigraphy and pulmonary ventilation, sputum stain test for acidfast bacilli, blood analyses, cardiologic assessment and pulmonary function tests (PFT).

Pulmonary Function Tests

The volume-time curve obtained by forced spirometry was performed according to the criteria standardized in 1995 by the American Thoracic Society (ATS) [20], with the best of three acceptable curves chosen. Forced vital capacity (FVC), forced expiratory volume in one second (FEV1), forced expiratory flow (FEF) between 25% - 75%, FEV1/FVC ratio, and peak expiratory flow (PEF) values were derived from the best curve. The normative reference values proposed by Pereira et al. in 2001 were used for all curves [21].

The comparison of impact of surgery on the variables (VC, FVC, FEV1, FEV1/FVC, FEF and PEF) at the 1st, 3rd, 6th and 12th month post-operatively versus preoperatively, was performed using the paired t test. The level of significance (a) applied for all tests was 5%, i.e. was deemed significant at p < 0.05.

3. Results

3.1. Interventions

11 patients were treated because of recurrent infections and 9 because of haemoptysis. The most common lobectomy was right upper lobectomy (7 patients), followed by left upper lobectomy (6 patients), left lower lobectomy (6 patients), and right middle lobectomy (1 patient). Therewere no postoperativecomplications. There was no postoperative mortality.

3.2. Vital Capacity

The mean VC value significantly decreased post-operatively from 2.83 L preoperatively to 2.12 L at the first postoperative month. It progressively increased to 2.43 L six months postoperatively, but differences still remained statistically significant compared with preoperative values (Figure 1).

Figure 1. Mean vital capacity (VC) values with standard deviations and calculated “p” values for comparison of preoperative and postoperative periods. A significant difference (p < 0.05) was observed in the means of the preoperative and postoperative periods for all three comparisons (preoperative and first month, preoperative and third month, preoperative and sixth month).

3.3. Forced Vital Capacity

As with VC, the mean FVC value also decreased one month after resection to progressively increase thereafter. However, at the sixth postoperative month, it still was significantly lower than the preoperative value (Figure 2).

3.4. Forces Expiratory Volume in One Second

The comparison of the mean values of FEV1 showed no statistically significant differences between the preoperative value and the value at six months postoperatively. However, there were statistically significant differences when the preoperative value was compared with those at the first and third postoperative months. In this case, a progressive recovery was observed during the first six months after lobectomy (Figure 3).

Figure 2. Mean forced vital capacity (FVC) values at the four timepoints: One preoperative and three postoperative. A statistically significant difference was found on comparison of the four timepoints (p < 0.05).

Figure 3. Mean forced expiratory volume in one minute (FEV1) values of the four timepoints: one preoperative and three postoperative. No statistically significant difference (p > 0.05) was found between the preoperative value and that at sixth months postoperatively, but a significant difference (p < 0.05) was evident for the other two comparisons (preoperative versus first month and preoperative versus third month). A progressive recovery of values was observed.

3.5. Peak Expiratory Flow

A significant decrease in PEF was observed across the postoperative period, with no significant recovery at six months postoperatively (Figure 4).

3.6. Forces Expiratory Volume in One Second/Forced Vital Capacity

Figure 5 depicts the mean values of FEV1/FVC of fourstages: pre-and postoperatively. There was nostatistically significant differences (p > 0.05) when compared with preoperative values. For this test, full recovery occurred six months after resection.

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1] C. A. Campos, E. Marchiore and R. Rodrigues, “Tuberculose Pulmonar: Achados na Tomografia Computadorizada de Alta Resolucao do Tórax em Pacientes com Doenca em Atividades Comprovada Bacteriologicamente,” Jornal de Pneumologia, Vol. 28, No. 2, 2002, pp. 23-29. doi:10.1590/S0102-35862002000100006?
[2] J. N. Muniz, A. Ruffino-Netto, M. Yamamura, T. C. S. Villa, R. Arcencio and R. I. Cardozo-Gonzales, “Aspectos Epidemiológicos da Co-Infeccao Tuberculose e Vírus da Imunodeficiência Humana em Ribeirao Preto (SP), de 1998 a 2003,” Jornal Brasileiro de Pneumologia, Vol. 32, No. 6, 2006, pp. 529-534. doi:10.1590/S1806-37132006000600010?
[3] S. Bombarda, C. M. Figueiredo, M. B. G. Funari, J. Soares Jr., M. Seiscento and M. Terra, “Imagem em Tuberculose pulmonar,” Jornal Brasileiro de Pneumologia, Vol. 27, No. 6, 2001, pp. 329-340.
[4] A. S. Ribeiro, “Tratamento Compulsório da Tuberculose: Avanco ou Retrocesso?” Jornal Brasileiro de Pneumologia, Vol. 29, No. 1, 2003, pp. 50-52.?
[5] M. P. T. Silveira, R. F. R. Adorno and T. Fontana, “Perfil dos Pacientes com Tuberculose e Avaliacao do Programa Nacional de Controle da Tuberculose em Bagé (RS),” Jornal Brasileiro de Pneumologia, Vol. 33, No. 2, 2007, pp. 199-205. doi:10.1590/S1806-37132007000200015?
[6] A. Ruffino-Netto, “Ttuberculose: A Calamidade Negligenciada,” Revista da Sociedade Brasileira de Medicina Tropical, Vol. 35, No. 1, 2002, pp. 51-58. doi:10.1590/S0037-86822002000100010
[7] Z. R. Cavalcanti, M. F. P. M. Albuquerque, A. R. L. Campello, R. Ximenes, U. Montarroyos and M. K. A. Vercosa, “Característica da Tuberculose em Idosos no Recife (PE): Contribuicao Para o Programa de Controle,” Jornal Brasileiro de Pneumologia, Vol. 32, No. 6, 2006, pp. 535-543. doi:10.1590/S1806-37132006000600011?
[8] Brasil, “Ministério da Saúde. Tuberculose no Brasil: Avancos e Perspectivas. Programa Nacional de Controle da Tuberculose,” 2010. http://www.sam.pmrp.com.br/ssaude/programas/tuberculose/tuberculose_no_brasil.pdf?
[9] A. Castelo Filho, A. L. Kritski, A. W. Barreto, A. C. M. Lemos, A. Ruffino Netto, C. A. Guimaroes, et al., “II Consenso Brasileiro de Tuberculose. Diretrizes Brasileiras para Tuberculose 2004,” Jornal Brasileiro de Pneumologia, Vol. 30, Suppl. 1, 2004, pp. S2-S56.?
[10] T. M. Fernandes, “Sol e Trevas: Histórias Sociais da Tu-Berculose Brasileira,” História, Ciências, Saúde-Manguinhos, Vol. 11, No. 3, 2004, pp. 767-771. doi:10.1590/S0104-59702004000300012
[11] J. F. Murray, “A Century of Tuberculosis,” American Journal of Respiratory and Critical Care Medicine, Vol. 169, No. 11, 2004, pp. 1181-1186. doi:10.1164/rccm.200402-140OE
[12] C. E. Gazetta, S. H. F. Vendramini, A. Ruffino-Netto, M. R. C. Oliveira and T. C. S. Villa, “Estudo Descritivo Sobre a Implantacao da Estratégia de Tratamento de Curta Duracao Diretamente Observado no Controle da Tuberculose em Sao José do Rio Preto e Seus Impactos (1998-2003),” Jornal de Pneumologia, Vol. 33, No. 2, 2007, pp. 192-198. doi:10.1590/S1806-37132007000200014?
[13] A. Gomes Neto, M. L. Medeiros and J. M. M. Gifoni, “Bronquiectasia Localizada e Multissegmentar: Perfil Clínico Epidemiológico e Resultado do Tratamento Cirúrgico de 67 Casos,” Jornal de Pneumologia, Vol. 27, No. 1, 2001, pp. 1-6. doi:10.1590/S0102-35862001000100002
[14] M. S. Guerra, J. A. Miranda, F. Leal and L. Vouga, “Tratamento Cirúrgico Das Bronquiectasias,” Revista Portuguesa de Pneumologia, Vol. 13, No. 5, 2007, pp. 691-701.
[15] K. Balkanli, O. Geno, M. Dakak, S. Gurkok, A. Gozubuyuk, H. Oaylakat, et al., “Surgical Management of Bronchiectasis: Analysis and Short-Term Results in 238 Patients,” European Journal Cardiothoracic Surgery, Vol. 24, No. 5, 2003, pp. 699-702. doi:10.1016/S1010-7940(03)00497-4?
[16] R. Saad Jr., T. Garrido, R. Stirbulov and F. Rafal, “Avaliacao da Funcao Respiratória de Doentes Submetidos à Operacao Abdominal Alta,” Rev. Col. Bras. Cir., Vol. 21, No. 6, 1994, pp. 329-332.?
[17] A. M. R. Pinto, “Estudo Comparativo da Funcao Pulmonar em Pacientes Pós-Revascularizados do Miocárdio, com CEC e sem CEC, com uso de Derivacao Intraluminal. Tese [Doutorado],” Faculdade de Ciências Médicas da Santa Casa de Misericórdia de Sao Paulo, Sao Paulo, 1999.?
[18] A. Helene Jr., “Avaliacao da Funcao Respiratória em In-Divíduos Submetidos à Abdominoplastia. Tese [Doutorado],” Faculdade de Ciências Médicas da Santa Casa de Misericórdia de Sao Paulo, Sao Paulo, 2005.?
[19] L. F. Perin, “Avaliacao Espirométrica de Indivíduos Submetidos à Dermolipectomia Abdominal. Tese [Mestrado],” Faculdade de Ciências Médicas Santa Casa de Misericórdia de Sao Paulo, Sao Paulo, 2007.?
[20] American Thoracic Society, “Standardization of Spirometry, 1994 Update. American Thoracic Society,” American Journal of Respiratory and Critical Care Medicine, Vol. 152, No. 3, 1995, pp. 1107-1136. doi:10.1164/ajrccm.152.3.7663792
[21] C. A. C. Pereira, “Testes de Funcao Pulmonar. Projeto Diretrizes. Associacao Médica Brasileira e Conselho Federal de Medicina,” 2001. http://www.projetodiretrizes.org.br/projeto_diretrizes/090.pdf?
[22] A. Helene Jr., “Avaliacao da Funcao Respiratória em Indivíduos Submetidos à Abdominoplastia. Tese [Doutorado],” Faculdade de Ciências Médicas da Santa Casa de Misericórdia de Sao Paulo, Sao Paulo, 2005.?
[23] M. Tercan, M. Bekerecioglu, O. Dikensoy, H. Kocoglu, B. Atik, D. Isik, et al., “Effects of Abdominoplasty on Respiratory Functions: A Prospective Study,” Annals of Plastic Surgery, Vol. 49, No. 6, 2002, pp. 617-620. doi:10.1097/00000637-200212000-00011

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.